A Quebecois man aged 64 has made history in North America by being the first recipient of a regenerated liver using groundbreaking technology that could potentially offer numerous additional livers for transplantation in its inaugural year. Gérard Landry, hailing from Nouvelle on Quebec’s Gaspé Peninsula, battled liver issues for around 15 years, leading to cirrhosis and liver cancer. Prior to his liver transplant surgery, he received surprising news from his doctor – his new liver had been regenerated by an innovative machine, utilized for the first time at Montreal’s Centre hospitalier de l’Université de Montréal (CHUM).
Describing the revelation, Landry expressed his elation, likening it to receiving a Christmas gift. The revolutionary technology, known as Liver Assist, enables medical professionals to treat and evaluate a donated liver outside the human body before the actual transplant. For Landry, this meant receiving an organ that might have otherwise been deemed too risky for transplantation.
The Liver Assist system, overseen by Dr. David Hénault, a hepatopancreatobiliary surgeon and liver transplant specialist at CHUM, was in preparation for about three years before being used on Landry. This system functions by connecting a donated liver to a machine that circulates an oxygen-rich fluid through the organ, potentially reversing some of the damage caused by oxygen deprivation while the liver is extracorporeal.
The technology then allows doctors to switch to a blood-based solution and assess the liver’s functionality under conditions simulating the human body. According to Hénault, if the liver performs well on the machine, it is likely to function optimally within a human body. The liver Landry received was an ideal candidate for this technology due to its susceptibility to oxygen-related damage during the organ transfer process.
The CHUM conducts approximately 70 liver transplants annually, and a study conducted with Transplant Québec evaluated previously declined livers to determine their recoverability through the new technology. The team estimates that the machine could make an additional 20 to 24 livers available for transplantation in its first year, with potential for further growth as the technology gains wider adoption.
Hénault noted that the technology has demonstrated a reduction in complications, reoperations, and hospital stays for suitable patients. Landry’s post-transplant recovery progress was notably positive, with his blood work showing better-than-expected results just one day after the operation.
While Landry continues his recovery in Montreal, returning to the hospital for regular blood tests, he looks forward to eventually returning to Gaspésie to continue recuperating. His experience has also inspired him to advocate for organ donation awareness, emphasizing the critical need for donated organs to complement even the most advanced medical technologies.